Consistent with expectations, the high‐AD group exhibited increased expression of PPARG, WNT16, BMP5, CREB3L3, CEBPA, FABP4, and CXCR4 compared to the low‐AD group (Figure 2D). Here, CREB3L3 is linked to Alzheimer disease.